- Condition: Infertility
Interventions: Drug: MK-8962; Drug: recFSH; Drug: Ganirelix; Drug: human Chorionic Gonadotropin (hCG); Drug: Progesterone
Sponsors: Schering-Plough; Schering-Plough
Not yet recruiting - verified May 2012 - Condition: Endometrial Cancer
Intervention: Device: MIrena(LNG-IUS), oral MPA
Sponsors: Korean Gynecologic Oncology Group; Korean Gynecologic Oncology Group
Recruiting - verified May 2012 - Condition: Chronic Hepatitis C
Interventions: Drug: Boceprevir; Drug: Peginterferon alpha-2b; Drug: Ribavirin; Drug: Boceprevir; Drug: Peginterferon alfa-2b; Drug: Ribavirin
Sponsors: Schering-Plough; Schering-Plough
Not yet recruiting - verified May 2012 - Condition: Tinea Pedis
Interventions: Drug: Butenafine HCl Cream, 1%; Drug: Lotrimin Ultra®; Drug: Butenafine Vehicle
Sponsors: Taro Pharmaceuticals USA; Taro Pharmaceuticals USA
Recruiting - verified April 2012 - Condition: Rheumatoid Arthritis
Intervention: Drug: A Natural Remedy for Rheumatoid Arthritis vs. 6 Common Drugs
Sponsors: University of Minnesota - Clinical and Translational Science Institute; University of Minnesota - Clinical and Translational Science Institute
Completed - verified May 2012 - Condition: Heartburn
Interventions: Drug: Omeprazole 20 mg; Drug: Omeprazole 20 mg + Sodium Bicarbonate 1100 mg
Sponsors: Schering-Plough; Schering-Plough
Active, not recruiting - verified May 2012 - Condition: Chronic Lymphocytic Leukemia (CLL)
Interventions: Drug: Dinaciclib; Drug: Ofatumumab
Sponsors: Schering-Plough; Schering-Plough
Not yet recruiting - verified May 2012 - Condition: Hypercholesterolaemia
Interventions: Drug: 10mg Ezetimibe; Drug: 10 mg Ezetimibe - wash out period
Sponsors: GlaxoSmithKline; GlaxoSmithKline
Completed - verified May 2012 - Condition: Asthma
Interventions: Drug: Mometasone Furoate/Formoterol Fumarate (MF/F) 100/5 mcg MDI; Drug: Mometasone Furoate/Formoterol Fumarate (MF/F) 200/5 mcg MDI
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Hepatitis C, Chronic
Interventions: Biological: peginterferon alfa-2a; Drug: ribavirin; Drug: boceprevir
Sponsors: Schering-Plough; Schering-Plough
Not yet recruiting - verified May 2012 - Condition: Alzheimer's Disease
Intervention: Drug: MK-8931
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Condition: Seasonal Allergic Rhinitis
Interventions: Drug: Mometasone furoate; Drug: Nasonex®; Drug: Placebo
Sponsors: Teva Pharmaceuticals USA; Teva Pharmaceuticals USA
Completed - verified January 2012 - Condition: Hepatitis C Chronic
Intervention:
Sponsors: Schering-Plough; Schering-Plough
Not yet recruiting - verified April 2012 - Condition: Healthy
Intervention: Drug: Desloratadine
Sponsors: Dr. Reddy's Laboratories Limited; Dr. Reddy's Laboratories Limited
Completed - verified May 2006 - Condition: Healthy
Intervention: Drug: Desloratadine
Sponsors: Dr. Reddy's Laboratories Limited; Dr. Reddy's Laboratories Limited
Completed - verified May 2006 - Condition: Asthma
Interventions: Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 25 mcg; Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 50 mcg; Drug: Mometasone Furoate (MF) Metered Dose Inhaler (MDI), 100 mcg; Drug: Mometasone Furoate (MF) Dry Powder Inhaler (DPI), 100 mcg; Drug: Placebo Metered Dose Inhaler (MDI); Drug: Placebo Dry Powder Inhaler (DPI)
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Endometrial Hyperplasia
Interventions: Drug: LNG-IUS; Mirena; Bayer Schering Pharma Oy, Finland; Drug: Norethisterone Acetate tablets
Sponsors: Mansoura University; Mansoura University
Completed - verified December 2011 - Condition: Parkinson's Disease
Intervention: Drug: SCH 900800
Sponsors: Schering-Plough; Schering-Plough
Not yet recruiting - verified March 2012 - Condition: Bipolar Disorder
Interventions: Drug: Asenapine; Drug: Aripiprazole; Drug: Quetiapine; Drug: Risperidone; Drug: Olanzapine; Drug: Ziprasidone; Drug: Iloperidone; Drug: Paliperidone; Drug: Lurasidone; Drug: Clozapine; Drug: Amisulpride; Drug: Sertindole; Drug: Zotepine
Sponsors: Schering-Plough; Schering-Plough
Not yet recruiting - verified April 2012 - Conditions: Bipolar Disorder; Schizophrenia
Intervention:
Sponsors: Schering-Plough; Schering-Plough
Not yet recruiting - verified April 2012 - Condition: Alzheimer's Disease
Interventions: Drug: MK-8931; Drug: Placebo
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Condition: Surgical Procedures, Elective
Interventions: Drug: Sugammadex; Drug: Neostigmine; Drug: Glycopyrrolate
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Condition: Contraception
Intervention: Drug: Ethinylestradiol + Etonogestrel Vaginal Ring (NuvaRing)
Sponsors: Schering-Plough; Schering-Plough
Active, not recruiting - verified March 2012 - Condition: Asthma
Interventions: Drug: Mometasone Furoate/Formoterol MDI 100/5 mcg; Drug: Mometasone Furoate/Formoterol MDI 200/5 mcg; Drug: Mometasone Furoate MDI 100 mcg; Drug: Mometasone Furoate MDI 200 mcg; Drug: Albuterol 90 mcg /salbutamol 100 mcg HFA MDI; Drug: Prednisone/prednisolone
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Rhinitis
Interventions: Drug: loratadine; Drug: fexofenadine; Drug: placebo to loratidine; Drug: placebo to fexofenadine
Sponsors: Schering-Plough; Schering-Plough
Completed - verified December 2011 - Condition: Healthy
Interventions: Drug: Placebo; Drug: Vorikonazole
Sponsors: Turku University Hospital; Turku University Hospital
Recruiting - verified November 2011 - Condition: Chronic Hepatic Impairment
Intervention: Drug: Preladenant
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Condition: Solid Tumors
Intervention: Drug: MK-8242
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Allergy
Interventions: Drug: SCH 39641 (MK-3641); Drug: Placebo for SCH 39641 (MK-3641)
Sponsors: Schering-Plough; Schering-Plough
Completed - verified April 2012 - Conditions: Stage IA Skin Melanoma; Stage IB Skin Melanoma; Stage IIA Skin Melanoma; Stage IIB Skin Melanoma; Stage IIC Skin Melanoma; Stage IIIA Skin Melanoma; Stage IIIB Skin Melanoma; Stage IIIC Skin Melanoma; Stage IV Skin Melanoma
Interventions: Biological: recombinant interferon alfa-2b; Other: laboratory biomarker analysis
Sponsors: Ohio State University Comprehensive Cancer Center; Ohio State University Comprehensive Cancer Center; Schering-Plough
Active, not recruiting - verified October 2011 - Condition: Spondylitis, Ankylosing
Interventions: Drug: Golimumab; Drug: Placebo
Sponsors: Schering-Plough; Schering-Plough; Johnson & Johnson
Recruiting - verified April 2012 - Condition: Acute Myelogenous Leukemia (AML)
Interventions: Drug: MK-8242; Drug: MK-8242; Drug: cytarabine
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Healthy
Intervention: Drug: Desloratadine and pseudoephedrine
Sponsors: Dr. Reddy's Laboratories Limited; Dr. Reddy's Laboratories Limited
Completed - verified June 2006 - Condition: Fungal Infections
Intervention: Drug: Posaconazole oral suspension 40 mg/mL
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified March 2012 - Condition: Central Nervous System Lymphoma
Intervention: Drug: Immunochemotherapy
Sponsors: University of Aarhus; University of Aarhus; Nordic Cancer Union; Roche Pharma AG; Mundipharma; Schering-Plough
Active, not recruiting - verified October 2011 - Condition: Renal Insufficiency
Intervention: Drug: Peginterferon alfa-2b
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Chronic Hepatitis C Genotype 1
Interventions: Drug: Boceprevir; Drug: Placebo; Drug: peginterferon alfa-2b; Drug: Ribavirin
Sponsors: Schering-Plough; Schering-Plough
Active, not recruiting - verified May 2012 - Condition: Hepatitis C, Chronic
Intervention: Drug: Boceprevir
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Conditions: Neuromuscular Blockade; Arthroplasty, Replacement, Hip; Arthroplasty, Replacement, Knee; Blood Coagulation; Antithrombotic Agents
Interventions: Drug: Sugammadex; Drug: neostigmine and glycopyrrolate or atropine; Drug: Placebo
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Conditions: Nasal Congestion; Rhinitis, Allergic, Seasonal
Interventions: Drug: Phenylephrine; Drug: Placebo; Drug: loratadine
Sponsors: Schering-Plough; Schering-Plough
Completed - verified December 2011 - Conditions: Hepatitis C; Renal Cell Carcinoma; Colorectal Cancer
Intervention: Other: Hepatitis C testing
Sponsors: Henry Ford Health System; Henry Ford Health System; Schering-Plough
Recruiting - verified June 2011 - Condition: Lymphoma
Interventions: Drug: Interferon-2A; Drug: Adriamycin; Drug: Bleomycin; Drug: Velban; Drug: Dacarbazine
Sponsors: M.D. Anderson Cancer Center; M.D. Anderson Cancer Center; Schering-Plough
Completed - verified December 2011 - Condition: Polymyalgia Rheumatica
Interventions: Drug: infliximab; Drug: inactive powder
Sponsors: Hospital Universitario Marqués de Valdecilla; Hospital Universitario Marqués de Valdecilla; Schering-Plough
Active, not recruiting - verified August 2011 - Condition: Bipolar I Disorder
Interventions: Drug: asenapine; Drug: asenapine
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Condition: Bipolar 1 Disorder
Interventions: Drug: asenapine; Drug: placebo
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified May 2012 - Condition: Agitation
Interventions: Drug: Asenapine; Drug: Placebo
Sponsors: St. Joseph Hospital Health Center; St. Joseph Hospital Health Center; Schering-Plough
Recruiting - verified April 2012 - Condition: Hepatitis C, Chronic
Interventions: Drug: Boceprevir (BOC); Drug: Placebo to boceprevir; Drug: Peginterferon alfa-2b (PEG); Drug: Ribavirin (RBV); Drug: Cross-Over Boceprevir Treatment
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Hepatitis C Virus
Interventions: Drug: boceprevir; Drug: methadone; Drug: buprenorphine/naloxone
Sponsors: Schering-Plough; Schering-Plough
Completed - verified January 2012 - Condition: Healthy
Intervention: Drug: Desloratadine and pseudoephedrine
Sponsors: Dr. Reddy's Laboratories Limited; Dr. Reddy's Laboratories Limited
Completed - verified June 2006 - Condition: Nasal Polyps
Interventions: Drug: Mometasone Furoate Nasal Spray (MFNS); Drug: Placebo for MFNS
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified April 2012 - Condition: Infertility, Female
Intervention: Drug: corifollitropin alfa
Sponsors: Schering-Plough; Schering-Plough
Recruiting - verified February 2012 - Condition: Pharmacokinetics and Pharmacodynamics of Sublingual Buprenorphine
Interventions: Drug: Placebo; Drug: vorikonazole; Drug: posakonazole
Sponsors: Turku University Hospital; Turku University Hospital
Completed - verified December 2010
 |
Schering-Plough - Database of Clinical Trials by Pharmaceutical Companies |
